RNA in Therapeutics: CRISPR in the Clinic

The advent of the CRISPR-Cas genome editing platform has greatly enhanced the capabilities of researchers in many areas of biology. Its use has also been turned to the development of therapies for genetic diseases and to the enhancement of cell therapies. This review describes some recent advances i...

Descripción completa

Detalles Bibliográficos
Autor principal: Carroll, Dana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society for Molecular and Cellular Biology 2023
Materias:
Minireview
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9880604/
https://www.ncbi.nlm.nih.gov/pubmed/36482771
http://dx.doi.org/10.14348/molcells.2022.0163
_version_ 1784878951451066368
author Carroll, Dana
author_facet Carroll, Dana
author_sort Carroll, Dana
collection PubMed
description The advent of the CRISPR-Cas genome editing platform has greatly enhanced the capabilities of researchers in many areas of biology. Its use has also been turned to the development of therapies for genetic diseases and to the enhancement of cell therapies. This review describes some recent advances in these areas.
format Online
Article
Text
id pubmed-9880604
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Korean Society for Molecular and Cellular Biology
record_format MEDLINE/PubMed
spelling pubmed-98806042023-02-08 RNA in Therapeutics: CRISPR in the Clinic Carroll, Dana Mol Cells Minireview The advent of the CRISPR-Cas genome editing platform has greatly enhanced the capabilities of researchers in many areas of biology. Its use has also been turned to the development of therapies for genetic diseases and to the enhancement of cell therapies. This review describes some recent advances in these areas. Korean Society for Molecular and Cellular Biology 2023-01-31 2022-12-09 /pmc/articles/PMC9880604/ /pubmed/36482771 http://dx.doi.org/10.14348/molcells.2022.0163 Text en © The Korean Society for Molecular and Cellular Biology. All rights reserved. https://creativecommons.org/licenses/by-nc-sa/3.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ (https://creativecommons.org/licenses/by-nc-sa/3.0/)
spellingShingle Minireview
Carroll, Dana
RNA in Therapeutics: CRISPR in the Clinic
title RNA in Therapeutics: CRISPR in the Clinic
title_full RNA in Therapeutics: CRISPR in the Clinic
title_fullStr RNA in Therapeutics: CRISPR in the Clinic
title_full_unstemmed RNA in Therapeutics: CRISPR in the Clinic
title_short RNA in Therapeutics: CRISPR in the Clinic
title_sort rna in therapeutics: crispr in the clinic
topic Minireview
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9880604/
https://www.ncbi.nlm.nih.gov/pubmed/36482771
http://dx.doi.org/10.14348/molcells.2022.0163
work_keys_str_mv AT carrolldana rnaintherapeuticscrisprintheclinic

Ejemplares similares